118 related articles for article (PubMed ID: 2531527)
1. Cytohistologic correlation of urothelial lesions secondary to photodynamic therapy.
Broghamer WL; Parker JE; Harty JI; Gilkey CM
Acta Cytol; 1989; 33(6):881-6. PubMed ID: 2531527
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy.
Nseyo UO
Urol Clin North Am; 1992 Aug; 19(3):591-9. PubMed ID: 1386168
[TBL] [Abstract][Full Text] [Related]
3. [Photodynamic therapy of superficial bladder cancer. An alternative to radical cystectomy?].
Kriegmair M; Waidelich R; Baumgartner R; Lumper W; Ehsan A; Hofstetter A
Urologe A; 1994 Jul; 33(4):276-80. PubMed ID: 7941172
[TBL] [Abstract][Full Text] [Related]
4. [Cytoscopic follow-up of initial G3T1 bladder tumors treated with BCG].
Pieras Ayala E; Palou J; Rodríguez-Villamil L; Millán Rodríguez F; Salvador Bayarri J; Vicente Rodríguez J
Arch Esp Urol; 2001 Apr; 54(3):211-7. PubMed ID: 11432035
[TBL] [Abstract][Full Text] [Related]
5. [Electron microscopic observation on human bladder cancer tissue after photodynamic therapy].
Zhou CN
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Jun; 10(3):176-8. PubMed ID: 2972405
[No Abstract] [Full Text] [Related]
6. [Photodynamic therapy (PDT) of bladder cancer. Report of 21 cases].
Xie JG
Zhonghua Zhong Liu Za Zhi; 1985 Mar; 7(2):113-5. PubMed ID: 4006674
[No Abstract] [Full Text] [Related]
7. Complications of whole bladder dihematoporphyrin ether photodynamic therapy.
Harty JI; Amin M; Wieman TJ; Tseng MT; Ackerman D; Broghamer W
J Urol; 1989 Jun; 141(6):1341-6. PubMed ID: 2524602
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional-cell carcinoma of the bladder.
Prout GR; Lin CW; Benson R; Nseyo UO; Daly JJ; Griffin PP; Kinsey J; Tian ME; Lao YH; Mian YZ
N Engl J Med; 1987 Nov; 317(20):1251-5. PubMed ID: 2959863
[TBL] [Abstract][Full Text] [Related]
9. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
Kumar A; Kumar R; Gupta NP
Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
[TBL] [Abstract][Full Text] [Related]
10. Should bladder biopsies be performed routinely after bacillus Calmette-Guérin treatment for high-risk superficial transitional cell cancer of the bladder?
Guy L; Savareux L; Molinié V; Botto H; Boiteux JP; Lebret T
Eur Urol; 2006 Sep; 50(3):516-20; discussion 520. PubMed ID: 16632184
[TBL] [Abstract][Full Text] [Related]
11. [Photodynamic therapy with hematoporphyrin derivative for transitional-cell carcinoma of the urinary bladder--report of 30 cases].
Tian ME
Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):304-6. PubMed ID: 2533889
[TBL] [Abstract][Full Text] [Related]
12. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
Skacel M; Fahmy M; Brainard JA; Pettay JD; Biscotti CV; Liou LS; Procop GW; Jones JS; Ulchaker J; Zippe CD; Tubbs RR
J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727
[TBL] [Abstract][Full Text] [Related]
13. Whole bladder photodynamic therapy for transitional cell carcinoma of bladder.
Nseyo UO; Dougherty TJ; Boyle DG; Potter WR; Wolf R; Huben R; Pontes JE
Urology; 1985 Sep; 26(3):274-80. PubMed ID: 2930927
[TBL] [Abstract][Full Text] [Related]
14. Polyoma virus-associated cellular changes in the urine and bladder biopsy samples: a cytohistologic correlation.
Herawi M; Parwani AV; Chan T; Ali SZ; Epstein JI
Am J Surg Pathol; 2006 Mar; 30(3):345-50. PubMed ID: 16538054
[TBL] [Abstract][Full Text] [Related]
15. Clinical application of NMP22 in the management of transitional cell carcinoma of the bladder.
Sawczuk IS; Bagiella E; Sawczuk AT; Yun EJ
Cancer Detect Prev; 2000; 24(4):364-8. PubMed ID: 11059567
[TBL] [Abstract][Full Text] [Related]
16. Prospective evaluation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder.
Lotan Y; Bensalah K; Ruddell T; Shariat SF; Sagalowsky AI; Ashfaq R
J Urol; 2008 Jun; 179(6):2164-9. PubMed ID: 18423745
[TBL] [Abstract][Full Text] [Related]
17. [Significance of random biopsies of healthy mucosa in superficial bladder tumor].
Fernández Gómez JM; Rodríguez Martínez JJ; Escaf Barmadah S; Pérez García J; García J; Casasola Chamorro J
Arch Esp Urol; 2000 Nov; 53(9):785-97. PubMed ID: 11196385
[TBL] [Abstract][Full Text] [Related]
18. Effect of intravesical instillation on performance of uCYT+ test.
Lodde M; Mian C; Negri G; Vittadello F; Comploj E; Palermo S; Staffler A; Brössner C; Pycha A
Urology; 2004 May; 63(5):878-81. PubMed ID: 15134970
[TBL] [Abstract][Full Text] [Related]
19. RE: Complications of whole bladder dihematoporphyrin ether photodynamic therapy.
J Urol; 1990 Sep; 144(3):750-1. PubMed ID: 2143790
[No Abstract] [Full Text] [Related]
20. Photodynamic therapy using porfimer sodium as an alternative to cystectomy in patients with refractory transitional cell carcinoma in situ of the bladder. Bladder Photofrin Study Group.
Nseyo UO; Shumaker B; Klein EA; Sutherland K
J Urol; 1998 Jul; 160(1):39-44. PubMed ID: 9628601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
